Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed

Yizhi Wang

Matched on ORCID iD 0000-0001-5279-5034; OpenAlex author ID A5083351215. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2019: 1 paper · 2020: 2 papers · 2021: 2 papers · 2022: 2 papers

Papers 7

  1. FGFR3 Nuclear Translocation Contributes to Proliferative Potential and Poor Prognosis in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000002056↗
  2. USPs in Pancreatic Ductal Adenocarcinoma: A Comprehensive Bioinformatic Analysis of Expression, Prognostic Significance, and Immune Infiltration. Co-author DOI 10.1155/2022/6109052↗
  3. ROBO2 hampers malignant biological behavior and predicts a better prognosis in pancreatic adenocarcinoma. Co-author DOI 10.1080/00365521.2021.1930144↗
  4. Aerial View of the Association Between m6A-Related LncRNAs and Clinicopathological Characteristics of Pancreatic Cancer. Co-author DOI 10.3389/fonc.2021.812785↗
  5. Ubiquitin-specific protease 4 predicts an unfavorable prognosis and promotes malignant behaviors in vitro in pancreatic cancer. Co-author DOI 10.1016/j.yexcr.2020.112317↗
  6. Research progress on long non-coding RNAs and their roles as potential biomarkers for diagnosis and prognosis in pancreatic cancer. Co-author DOI 10.1186/s12935-020-01550-y↗
  7. Research progress on circularRNAs in pancreatic cancer: emerging but promising. Co-author DOI 10.1080/15384047.2019.1617563↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jun Lü · 5 shared papers, 2019–2022 · strength 0.63
  2. Li Zhou · 4 shared papers, 2020–2022 · strength 0.51
  3. Bolun Jiang · 3 shared papers, 2020–2022 · strength 0.40
  4. Junchao Guo · 3 shared papers, 2019–2022 · strength 0.39
  5. Zhiyong Liang · 2 shared papers, 2020–2022 · strength 0.27
  6. Junchao Guo · 2 shared papers, 2020 · strength 0.24
  7. Yuan Ding · 1 shared paper, 2022 · strength 0.19
  8. Dongkai Zhou · 1 shared paper, 2022 · strength 0.19
  9. Weilin Wang · 1 shared paper, 2022 · strength 0.19
  10. Lei You · 1 shared paper, 2022 · strength 0.15
  11. Shunda Wang · 1 shared paper, 2021 · strength 0.14
  12. Cheng Ding · 1 shared paper, 2021 · strength 0.14
  13. Hanyu Zhang · 1 shared paper, 2021 · strength 0.14
  14. Menghua Dai · 1 shared paper, 2021 · strength 0.14
  15. Gary Guishan Xiao · 1 shared paper, 2020 · strength 0.13
  16. Bingqi Li · 1 shared paper, 2019 · strength 0.12
  17. Jianzhou Liu · 1 shared paper, 2021 · strength 0.11
  18. Yu Wang · 1 shared paper, 2021 · strength 0.11
  19. Bowen Huang · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.